These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8626728)
21. Recruiting the 2-5A system for antisense therapeutics. Torrence PF; Xiao W; Li G; Cramer H; Player MR; Silverman RH Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):203-6. PubMed ID: 9212911 [No Abstract] [Full Text] [Related]
22. A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L. Townsend HL; Jha BK; Han JQ; Maluf NK; Silverman RH; Barton DJ RNA; 2008 Jun; 14(6):1026-36. PubMed ID: 18426919 [TBL] [Abstract][Full Text] [Related]
23. Purine 8-bromination modulates the ribonuclease L binding and activation abilities of 2',5'-oligoadenylates. Possible influence of glycosyl torsion angle. Lesiak K; Torrence PF J Biol Chem; 1987 Feb; 262(5):1961-5. PubMed ID: 3818584 [TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationship of analogs of 2-5A determined using the core-cellulose assay for 2-5A-dependent RNase. Krause D; Lesiak K; Imai J; Sawai H; Torrence PF; Silverman RH Prog Clin Biol Res; 1985; 202():133-9. PubMed ID: 3832069 [No Abstract] [Full Text] [Related]
25. Synthesis of 2',5'-oligoadenylate analogs possessing a linker moiety in the place of the second adenosine and their ability to activate human RNase L. Nakamura T; Ito Y; Mochizuki M; Ueno Y; Kitade Y Nucleic Acids Symp Ser (Oxf); 2007; (51):449-50. PubMed ID: 18029780 [TBL] [Abstract][Full Text] [Related]
26. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease. Karikó K; Sobol RW; Suhadolnik L; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W Biochemistry; 1987 Nov; 26(22):7127-35. PubMed ID: 3427062 [TBL] [Abstract][Full Text] [Related]
27. 5'-modified agonist and antagonist (2'-5')(A)n analogues: synthesis and biological activity. Bisbal C; Silhol M; Lemaître M; Bayard B; Salehzada T; Lebleu B; Perrée TD; Blackburn MG Biochemistry; 1987 Aug; 26(16):5172-8. PubMed ID: 3117112 [TBL] [Abstract][Full Text] [Related]
28. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates. Xiang Y; Wang Z; Murakami J; Plummer S; Klein EA; Carpten JD; Trent JM; Isaacs WB; Casey G; Silverman RH Cancer Res; 2003 Oct; 63(20):6795-801. PubMed ID: 14583476 [TBL] [Abstract][Full Text] [Related]
29. Dissection of the roles of adenine ring nitrogen (N-1) and exocyclic amino (N-6) moieties in the interaction of 2-5A with RNase L. Player MR; Kalinichenko EN; Podkopaeva TL; Mikhailopulo IA; Seela F; Torrence PF Biochem Biophys Res Commun; 1998 Apr; 245(2):430-4. PubMed ID: 9571169 [TBL] [Abstract][Full Text] [Related]
30. Molecular basis for recognition of 2',5'-linked oligoadenylates by the N-terminal ankyrin repeat domain of human ribonuclease L. Tanaka N; Nakanishi M; Kusakabe Y; Goto Y; Kitade Y; Nakamura KT Nucleic Acids Symp Ser (Oxf); 2005; (49):323-4. PubMed ID: 17150764 [TBL] [Abstract][Full Text] [Related]
31. Phosphorothioate analogues of 2',5'-oligoadenylate. Activation of 2',5'-oligoadenylate-dependent endoribonuclease by 2',5'-phosphorothioate cores and 5'-monophosphates. Karikó K; Li SW; Sobol RW; Suhadolnik RJ; Charubala R; Pfleiderer W Biochemistry; 1987 Nov; 26(22):7136-42. PubMed ID: 3427063 [TBL] [Abstract][Full Text] [Related]
32. Recognition of 2',5'-linked oligoadenylates by human ribonuclease L: molecular dynamics study. Maláč K; Barvík I J Mol Model; 2014 Apr; 20(4):2123. PubMed ID: 24633766 [TBL] [Abstract][Full Text] [Related]
33. Antimitogenic effects of interferon and (2'-5')-oligoadenylate in synchronized 3T3 fibroblasts. Kimchi A; Shure H; Lapidot Y; Rapoport S; Panet A; Revel M FEBS Lett; 1981 Nov; 134(2):212-6. PubMed ID: 6171460 [No Abstract] [Full Text] [Related]
35. Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity. Huang H; Zeqiraj E; Dong B; Jha BK; Duffy NM; Orlicky S; Thevakumaran N; Talukdar M; Pillon MC; Ceccarelli DF; Wan LC; Juang YC; Mao DY; Gaughan C; Brinton MA; Perelygin AA; Kourinov I; Guarné A; Silverman RH; Sicheri F Mol Cell; 2014 Jan; 53(2):221-34. PubMed ID: 24462203 [TBL] [Abstract][Full Text] [Related]
36. Small-molecule activators of RNase L with broad-spectrum antiviral activity. Thakur CS; Jha BK; Dong B; Das Gupta J; Silverman KM; Mao H; Sawai H; Nakamura AO; Banerjee AK; Gudkov A; Silverman RH Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9585-90. PubMed ID: 17535916 [TBL] [Abstract][Full Text] [Related]
37. (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection. Schröder HC; Suhadolnik RJ; Pfleiderer W; Charubala R; Müller WE Int J Biochem; 1992; 24(1):55-63. PubMed ID: 1374726 [TBL] [Abstract][Full Text] [Related]
38. Mechanistic insights into RNase L through use of an MDMX-derived multi-functional protein domain. Garvie CW; Vasanthavada K; Xiang Q Biochim Biophys Acta; 2013 Aug; 1834(8):1562-71. PubMed ID: 23608948 [TBL] [Abstract][Full Text] [Related]
39. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice. Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557 [TBL] [Abstract][Full Text] [Related]
40. Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L. Nagaoka K; Kito S; Kitamura Y; Ueno Y; Kitade Y Nucleic Acids Symp Ser (Oxf); 2009; (53):123-4. PubMed ID: 19749291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]